The Governor of Tasmania has supported Macular Degeneration Awareness Week 2015 by accepting the role of Custodian of Vision.
MDFA says the addition of ranibizumab (Lucentis) to the Pharmaceutical Benefits Scheme provides patients with affordable access to treatment for diabetic macular oedema and retinal vein occlusion.
MDFA has voiced its concern regarding the economic impact of diabetic macular oedema (DMO) in Australia.
We’ve audited the six largest health funds to find out the benefits they offer for low vision aids and technology.
Winners of the 2014 mEYE World Photographic Competition have brilliantly captured the competition’s theme – ‘a sight worth saving’.
Australians affected by diabetes are being urged to take regular eye tests to reduce the risk of serious vision loss or blindness.
After extensive lobbying by MDFA, SA Health has confirmed funding for an additional seven eye clinics per month.
MDFA has been advocating for our community on the issue of PIN-only authorisation credit cards.
MDFA has welcomed new treatment options for diabetic macular oedema and retinal vein occlusion.